Friday, April 12th 10:00–10:10 AM External Validation of a Risk Score Assessment for Pediatric Ventricular Assist Device Mortality Meaghan Reaney, DO, et al.
Thursday, April 11th 4:36–4:40 PM VAD Support Can Effectively Bridge Pediatric Patients to Heart Re-Transplant: An ACTION Study Stevan Lukich, MD, et al.
Thursday, April 11th 4:30–4:34 PM SGLT2i Use in Pediatric Heart Failure: Multicenter Study Ryan Butts, MD, et al.
ACTION @ ISHLT ’24: SGLT2i Use in Pediatric Heart Failure: Multicenter Study Read More »
Wednesday, April 10th 5:15–5:25 PM Double Bridge to Heart Transplantation: Outcomes of Early vs Delayed ECMO Crossover in the Pediatric Population – An Analysis of the ACTION Registry Kishore Raja,
Check out our educational handout on An Introduction to Myocarditis. Included is information about: What is Myocarditis? How is it diagnosed? What are the causes and the symptoms? Treatment options
An Introduction to Myocarditis Read More »
Ventricular assist device (VAD) use for failed stage II palliation (S2P) is increasing with limited data on outcomes.
The HeartWare ventricular assist device (HVAD) was discontinued in July 2021. The study aims to describe the impact the discontinuation the HVAD had on pediatric ventricular assist device (VAD) utilization and outcomes.
Patients with Fontan failure are high-risk candidates for heart transplantation and other advanced therapies. Understanding the outcomes following initial heart failure consultation can help define appropriate timing of referral for advanced heart failure care.
Outcomes after initial heart failure consultation in Fontan patients Read More »
Ricky was diagnosed with Duchenne Muscular Dystrophy (DMD) within the first year of his life. With the unyielding support of his mother, Rosie, he has defied the odds of a complex disease. From diagnosis to treatment, and now recovery, Ricky goes everywhere, experiencing life to the fullest.
Care Across State Lines: Ricky’s Journey to Life-Saving Surgery Read More »
Abstract Adult patients on left ventricular assist device (LVAD) support have increased morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There are no reported clinical data
